Novartis Wants To Question Bone Patients' Doctors

Law360, New York (November 13, 2007, 12:00 AM EST) -- Locked in a product liability war over its bone cancer drugs, Novartis Pharmaceuticals Corp. is seeking court permission to engage in talks with the plaintiffs’ treating and prescribing physicians in an effort to expedite discovery.

On Monday, Novartis beseeched the court to recognize the pharmaceutical giant's right to conduct ex parte communications with the doctors involved, arguing that the process would improve efficiency in the case.

“Because there is no substantive federal prohibition on ex parte contacts and because 30 of the 34 states in which...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.